Artículos del autor

solaci

Coronary disease

EuroCTO: Rechanneling vs. Optimal Medical Treatment in Total Occlusions

Courtesy of the SBHCI. Chronic total occlusions represent around 18% of all coronary lesions. However, they account for...
solaci -
DAY 3

COMPARE-ACUTE: FFR-Guided Non-Culprit Vessel Revascularization in Primary Angioplasty

Courtesy of the SBHCI. About 50% of patients admitted with acute ST-segment elevation myocardial infarction also present lesions...
solaci -
DAY 3

AIDA: bioresorbable scaffold thrombosis still a concern in studies

Courtesy of the SBHCI. This study presented at PCR and simultaneously published by NEJM still challenges the safety...
solaci -
Structural heart disease

Low Gradient Aortic Stenosis Won’t Improve with TAVR

Courtesy of Dr. Carlos Fava. It is known that patients with low gradient aortic stenosis show poor evolution...
solaci -
Structural heart disease

Amplatzer and Figulla Devices Prove to Be Safe for Percutaneous Patent Foramen Ovale Closure

Courtesy of Dr. José Álvarez. In patients with presumed paradoxical embolism through a patent foramen ovale (PFO) who...
solaci -
Coronary disease

Nearly half of interventional cardiologists may have pre-cataract lesions

This statement is based on eye exams conducted during the last SCAI meeting (Society for Cardiovascular Angiography...
solaci -
Coronary disease

PRISON IV: DES with resorbable polymer vs. DES with permanent polymer in total occlusions

Courtesy of SBHCI. The PRISON IV trial compared the sirolimus eluting stent with ultra-thin struts and biodegradable polymer...
solaci -
DAY 3

[SURTAVI] Sub-study of neurological events: more evidence in favor of TAVR

Courtesy of SBHCI. The occurrence of a periprocedural neurological events is associated to an increased risk of death...
solaci -